Towards subtypes — deep endometriosis oestrogen receptor-α expression

Most research treats endometriosis as a single entity, potentially obscuring informative subtype-specific associations with risk factors, biomarkers and treatment responses. A 2020 study raises the hypothesis that deep endometriosis oestrogen receptor-α expression might be associated with progestin treatment and the degree of post-surgical excision pain.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


  1. 1.

    Zondervan, K. T., Becker, C. M. & Missmer, S. A. Endometriosis. N. Eng. J. Med. 382, 1244–1256 (2020).

    CAS  Article  Google Scholar 

  2. 2.

    Zondervan, K. T. et al. Endometriosis. Nat. Rev. Dis. Primers 4, 9 (2018).

    PubMed  Article  Google Scholar 

  3. 3.

    Pluchino, N. et al. Estrogen receptor-α immunoreactivity predicts symptom severity and pain recurrence in deep endometriosis. Fertil. Steril. 113, 1224–1231 (2020).

    CAS  PubMed  Article  Google Scholar 

  4. 4.

    Becker, C. M., Gattrell, W. T., Gude, K. & Singh, S. S. Reevaluating response and failure of medical treatment of endometriosis: a systematic review. Fertil. Steril. 108, 125–136 (2017).

    PubMed  PubMed Central  Article  Google Scholar 

  5. 5.

    Brichant, G. et al. Heterogeneity of estrogen receptor α and progesterone receptor distribution in lesions of deep infiltrating endometriosis of untreated women or during exposure to various hormonal treatments. Gynecol. Endocrinol. 34, 651–655 (2018).

    CAS  PubMed  Article  Google Scholar 

  6. 6.

    American Society for Reproductive Medicine. Revised American Society for Reproductive Medicine classification of endometriosis: 1996. Fertil. Steril. 67, 817–821 (1997).

    Article  Google Scholar 

  7. 7.

    Schliep, K. C. et al. Pain typology and incident endometriosis. Hum. Reprod. 30, 2427–2438 (2015).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  8. 8.

    Gaudet, M. M. et al. Pooled analysis of nine cohorts reveals breast cancer risk factors by tumor molecular subtype. Cancer Res. 78, 6011–6021 (2018).

    CAS  PubMed  PubMed Central  Google Scholar 

  9. 9.

    Dawood, S. et al. Defining breast cancer prognosis based on molecular phenotypes: Results from a large cohort study. Breast Cancer Res. Treat. 126, 185–192 (2011).

    PubMed  Article  Google Scholar 

  10. 10.

    Zyzanski, S. J., Flocke, S. A. & Dickinson, L. M. On the nature and analysis of clustered data. Ann. Fam. Med. 2, 199–200 (2004).

    PubMed  PubMed Central  Article  Google Scholar 

Download references


The authors acknowledge the support of Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) grants R01 HD094842 and R21 HD096358.

Author information



Corresponding author

Correspondence to Amy L. Shafrir.

Ethics declarations

Competing interests

S.M. serves as an advisory board member for AbbVie and served as a working group member for Roche. A.S. and S.M. receive funding support from the J. Willard and Alice S. Marriott and the Marriott Daughters’ Foundations – all unrelated to this work.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Shafrir, A.L., Missmer, S.A. Towards subtypes — deep endometriosis oestrogen receptor-α expression. Nat Rev Endocrinol 16, 541–542 (2020).

Download citation


Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing